NCT06326190 2025-09-16
LUMEN-1
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Recruiting
Clinical Trials
5 trialsNCT00255788 2023-08-04
Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT02031536 2023-06-29
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT00886691 2022-02-04
Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Completed
NCT01804374 2015-06-17
SERIO
Italian Sarcoma Group
Phase 2 Completed